Dietary vitamin D supplementation for post- menopausal wome
Phase 2
- Conditions
- Health Condition 1: E559- Vitamin D deficiency, unspecified
- Registration Number
- CTRI/2023/02/049526
- Lead Sponsor
- Founder Chancellor Shri NPV Ramasamy Udayar Research Fellowship
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Women who had natural menopause at the age of 45 years and above ( < 70 years)
2) Patient who has been diagnosed with vitamin D deficiency <20 ng/ml
Exclusion Criteria
1) Renal failure/liver failure/intestinal malabsorption/ seizure disorder/ antiepileptic drugs/ pancreatic disorder, on steroid therapy, cholestyramine and on hormonal replacement therapy
2) Any supplementation / preparation with cholecalciferol > 1000 IU/day or active vitamin D (calcitriol)
3) Any patient who has been receiving loading doses of cholecalciferol in the last 6 months
4) Not willing to give informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increase in serum vitamin D levels of post menopausal womenTimepoint: The serum levels of vitamin D will be checked at baseline, after every two weeks of supplementation and after 12 weeks of supplementation
- Secondary Outcome Measures
Name Time Method Increase in serum calcium, phosphorous, albumin, alkaline phosphatase and parathyroid hormoneTimepoint: The serum levels will be checked at the baseline and after 12 weeks of supplementation